Methacholine Challenge Test: Procedure and Performance
What Happens During the Test
A methacholine challenge test involves inhaling progressively increasing concentrations of methacholine aerosol while repeatedly measuring lung function (spirometry) after each dose until airways narrow by ≥20% or the maximum dose is reached. 1, 2
Pre-Test Requirements
Baseline Spirometry
- Perform at least 3 acceptable FEV₁ maneuvers with the best two values agreeing within 0.10-0.20 L 2, 3
- Record the highest FEV₁ value as baseline 2, 3
- Baseline FEV₁ must be ≥60% predicted and ≥1.5 L in adults – values below this are absolute contraindications 1, 2, 3
Medication Withholding
- Short-acting β₂-agonists: withhold 8 hours 2
- Long-acting β₂-agonists: withhold 48 hours 2
- Theophylline: withhold 24-48 hours 2
- Anticholinergics: withhold 24 hours 2
- Testing should occur within 24 hours of workplace exposure for occupational asthma evaluation 4
Step-by-Step Test Procedure
Step 1: Diluent (Saline) Inhalation
- Inhale nebulized saline as a control 1, 3
- Measure FEV₁ at 30 and 90 seconds post-inhalation 2, 3
- If FEV₁ falls ≥20% after diluent alone, this constitutes a positive test – stop and do not proceed with methacholine 2, 3
- If FEV₁ falls <20%, use the higher value between baseline and post-diluent as the reference for calculating subsequent declines 3, 5
Step 2: Incremental Methacholine Dosing
Two standardized protocols are endorsed by the American Thoracic Society 1, 2:
5-Breath Dosimeter Method:
- Patient inhales 5 breaths of methacholine at each concentration 2, 3
- Concentrations: 0.0625,0.25,1.0,4.0,16.0 mg/mL 2, 3
2-Minute Tidal Breathing Method:
- Patient breathes normally through nebulizer for 2 minutes at each concentration 2, 3
- Same concentration progression as dosimeter method 2, 3
Step 3: Spirometry After Each Dose
- Measure FEV₁ at 30 seconds and 90 seconds after completing each methacholine inhalation 2, 3
- Only acceptable FEV₁ measurements are required (complete FVC maneuvers are unnecessary during testing) 5
- Calculate percent fall: [(post-diluent FEV₁ - lowest post-methacholine FEV₁) / post-diluent FEV₁] × 100 1, 3
- Stop immediately if FEV₁ falls ≥20% from post-diluent baseline 2, 3
- Stop if maximum concentration (16 mg/mL) is reached 2, 3
- Interval between consecutive doses should not exceed 3 minutes 5
Step 4: Bronchodilator Administration and Recovery
- Administer 200-400 µg albuterol (2-4 puffs) immediately after reaching positive threshold 2, 3
- Wait 10 minutes and remeasure FEV₁ 3
- Patient cannot leave until FEV₁ recovers to within 90% of baseline 2, 3
- If recovery is inadequate after 10 minutes, repeat bronchodilator or add ipratropium 5
- Most patients recover within 5 minutes with bronchodilator; without bronchodilator, recovery takes 30-45 minutes 3
Test Interpretation
Positive Test Definition
- ≥20% reduction in FEV₁ from post-diluent baseline 2, 3
- PC₂₀ (provocative concentration causing 20% fall) is calculated by linear interpolation between the last two concentrations 1, 3
Severity Grading (American Thoracic Society) 1, 2
| PC₂₀ (mg/mL) | Interpretation |
|---|---|
| >16 | Normal (negative test) |
| 4-16 | Borderline hyperresponsiveness |
| 1-4 | Mild hyperresponsiveness (positive) |
| <1 | Moderate-severe hyperresponsiveness |
- For children, the European Respiratory Society uses PC₂₀ ≤8 mg/mL as the positive threshold 2
Safety Equipment and Monitoring
Required Emergency Equipment 1, 2
- Rapid-acting inhaled bronchodilators (albuterol, ipratropium) immediately available
- Supplemental oxygen
- Small-volume nebulizer
- Pulse oximeter and blood pressure monitor
- Stethoscope
Common Adverse Effects
- Transient cough, wheezing, dyspnea, chest tightness occur in 20-25% of patients 2
- Symptoms are mild, last only minutes, and resolve with bronchodilator 1
- Severe bronchoconstriction is rare but requires immediate bronchodilator treatment 1, 3
Critical Pitfalls to Avoid
- Never perform the test if baseline FEV₁ <60% predicted – this is an absolute contraindication that increases risk without diagnostic benefit 1, 2, 3
- Inadequate medication withholding produces false-negative results 2
- Poor-quality spirometry maneuvers yield unreliable measurements 1, 2
- Testing rooms require adequate ventilation to minimize technician aerosol exposure 1
- A positive test does not automatically confirm asthma – bronchial hyperresponsiveness occurs in COPD, heart failure, allergic rhinitis, and other conditions 1
- The test has excellent negative predictive value but mediocre positive predictive value – it is more useful for excluding asthma than confirming it 1